VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Novo Nordisk A/S vs TransDigm Group Incorporated
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Novo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisTransDigm Group Incorporated
TDG · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into TransDigm Group Incorporated's moat claims, evidence, and risks.
View TDG analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 84 / 100 for TransDigm Group Incorporated).
- Segment focus: Novo Nordisk A/S has 3 segments (71.1% in Diabetes care); TransDigm Group Incorporated has 3 segments (51.6% in Power & Control).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Strong.
- Moat breadth: Novo Nordisk A/S has 5 moat types across 3 domains; TransDigm Group Incorporated has 5 across 3.
Primary market context
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
TransDigm Group Incorporated
Power & Control
Highly engineered aerospace power & control components (OEM and aftermarket)
Global
Commercial airlines, aircraft OEMs, defense OEMs, governments, aerospace distributors
Tier 2/3 component OEM, aftermarket spares, repair/overhaul
51.6%
Side-by-side metrics
Moat coverage
Shared moat types
Novo Nordisk A/S strengths
TransDigm Group Incorporated strengths
Segment mix
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
TransDigm Group Incorporated segments
Full profile >Power & Control
Competitive
Airframe
Competitive
Non-aviation
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.